1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Medical - Equipment & Services
St. Jude Medical, Inc.

St. Jude Medical, Inc.

STJ
St. Jude Medical, Inc.US flagNew York Stock Exchange
80.82
USD
+0.01
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
Sector
Healthcare
Industry
Medical - Equipment & Services
Address
United Kingdom
IPO Date
Dec 7, 1989
CIK
0000203077
Similar Companies
Imaging Diagnostic Systems, Inc. (IMDS)
Landauer Inc. (LDR)
Scientific and Medical Equipment House (4014.SR)
Bruker Corporation (BRK)
Beta Bionics, Inc. (BBNX)
Meridian Bioscience, Inc. (0K0K.L)
Business
St. Jude Medical, Inc. (STJ) develops, manufactures and distributes cardiovascular medical devices worldwide; its core products include mechanical and tissue heart valves, implantable cardioverter-defibrillators, pacemakers with quadripolar lead technology, cardiac resynchronization therapy devices, electrophysiology catheters, vascular closure systems such as Angio-Seal, cardiac mapping and visualization systems, optical coherence tomography imaging platforms like Ilumen Optis, structural heart repair products, neurostimulation devices for chronic pain management and heart failure monitoring solutions including CardioMEMS; the company targets physicians and healthcare providers serving patients with cardiac rhythm disorders, structural heart disease, atrial fibrillation and vascular conditions, with major operations spanning the United States, Europe, Latin America, Asia-Pacific and more than 100 countries overall from over 20 manufacturing facilities. Founded in 1976 and headquartered in Little Canada, Minnesota, the company maintains technology centers in locations including Brussels, Beijing, Tokyo, Austin and St. Paul to support physician training and procedure simulation. St. Jude Medical underwent a major strategic shift with its $25 billion acquisition by Abbott Laboratories, completed in January 2017, integrating its portfolio into Abbott's medical device business while divesting certain vascular closure assets to Terumo Corporation for $1.12 billion in late 2016; subsequent operational changes encompassed leadership transition to Michael T. Rousseau as CEO in 2016 and business reorganization into consolidated research/development and manufacturing/supply chain divisions.

Company News

APIChatGPT